Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the α(v)β3 integrin

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1929-1935

  Barillari, Giovanni ^a   Sgadari, Cecilia ^a   Palladino, Clelia ^a   Gendelman, Rita ^a   Caputo, Antonella ^b   Morris, Cindy Bohan ^c   Nair, Bala C ^d   Markham, Philip ^d   Nel, Andrè ^e   Stürzl, Michael ^f   Ensoli, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^e Division of Clinical Immunology and Allergy   (United States)

^f Gesell Strahlung U   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTEGRIN; TRANSACTIVATOR PROTEIN; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS GENE;

ANIMALS; ANTIGENS, CD; CELL ADHESION; CELL DIVISION; CELL LINE; CELL MOVEMENT; CYTOKINES; DRUG SYNERGISM; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCTS, TAT; HIV-1; HUMANS; INJECTIONS, SUBCUTANEOUS; INTEGRIN BETA CHAINS; INTEGRIN BETA3; INTEGRINS; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, VITRONECTIN; SARCOMA, KAPOSI; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033566827     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Barrè-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Charmaret, J. Gruest, C. Dauget, C. Axler-Blin, F. Vezinet-Brun, C. Rouzíoux, et al. 1983. Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome. Science 220:868.
2. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Safai, et al. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500.
3. Cullen, B. R., and W. C. Greene. 1989. Regulatory pathways governing HIV-1 replication. Cell 58:423.
4. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal. 1982. Transactivator gene of human T lymphotropic virus type III (HTLV-III). Science 229:69.
5. Ensoli, B., G. Barillari, S. Z. Salahuddin, S. Z. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates the growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84.
6. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfeld, and R.C. Gallo. 1993. Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277.
7. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli. 1997. HIV-1 Tat protein exits from intact cells via a leaderless secretory pathway and binds to extracellular matrix associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421.
8. Ensoli, B., R. Geddelman, P. D. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674.
9. Westendorf, M. O., R. Frank, C. Ochsenbauer, K. Stricker, K. Dhein, H. Walchzak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
10. Safai, B., K. G. Johnson, S. Myskowsky, S. Cunningham-Randles, J. H. Godbold, and D. Dupont. 1985. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:744.
11. Ensoli, B., and M. Stürzl. 1998. M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:63.
12. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine activated vascular cells induces adhesion of the same cell types by using integrin receptors recognizing the ROD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
13. Albini, A., G. Barillari, R. Benelli, R. C. Gallo, and B. Ensoli. 1995. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 92:4836.
14. Regezi, S. A., L. A. MacPhail, and T. E. Daniels. 1993. Human immunodeficiency virus-associated Kaposi's sarcoma: an heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 43:240.
15. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R. C. Gallo, and B. Ensoli. 1992. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implication for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727.
16. Fiorelli, V., R. Gendelman, F. Samaniego, P. D. Markham, and B. Ensoli. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95:1723.
17. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat. Blood 91:956.
18. Fiorelli, V., G. Barillari, E Toschi, C. Sgadari, P. Monini, M. Sturzl, and B. Ensoli. 1999. Interferon-γ induces endothelial cells to proliferate and to invade the extracellular matrix in response to HIV-1 Tat. J. Immunol. 162:1165.
19. Lepe Zanuga, J. L., P. W. A. Mansell, and E. M. Hersh. 1987. Idiopathic production of interleukin 1 in acquired immunodeficiency syndrome. J. Clin. Microbiol. 25:1695.
20. Lahdervita, J. C., P. J. Maury, A. M. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289.
21. Hober, D. A., A. Haque, P. Waltre, G. Beaucaire, Y. Mouton, and A. Capron. 1989. Production of TNFα and IL-1 in patients with AIDS: enhanced level of TNFα is related to higher cytotoxic activity. Clin. Exp. Immunol. 78:329.
22. Oxholm, A., P. Oxholm, H. Permin, and L. Bendtzen. 1989. Epidermal tumor necrosis factor α and interleukin 6-like activities in AIDS-related Kaposi's sarcoma: an immunohistological study. APMIS 97:533.
23. Fan, J., H. Z. Bass, and I. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV-1 infection. J. Immunol. 152:5031.
24. Sirianni, M. C., L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, et al. 1998. γ-interferon production in peripheral blood mononuclear cells (PBMC) and tumor infiltrating lymphocytes from Kaposi's sarcoma patients correlation with the presence of human herpesvirus 8 in PBMC and lesional macrophages. Blood 91:968.
25. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo. 1989. AIDS-Kaposi's sarcoma derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223.
26. Ensoli, B., P. D. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-KS cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor. J. Clin. Invest. 94:1736.
27. Xerri, L., J. Houssoun, J. Planche, V. Guigou, J. J. Grob, P. Parc, D. Birnbaum, and O. De Lapeyriere. 1991. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am. J. Pathol. 138:9.
28. Folkman, J., and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267:10931.
29. 5, integrin to the basic domain of the HIV-1 Tat protein and vitronectin. J. Cell Biol. 121:461.
30. Kubota, Y., H. K. Kleinman, G. R. Martin, and T. Lawley. 1988. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107:1589.
31. Hayman, E. G., M. D. Piershbacher, and E. Ruoslahti. 1985. Detachment of cells from culture substrate by soluble fibronectin peptides. J. Cell Biol. 100:1948.
32. Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111:765.
33. Samaniego, F., P. D. Markham, R. C. Gallo, and B. Ensoli. 1995. Inflammatory cytokines induce AIDS-Kaposi's sarcoma derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154:3582.
34. Samaniego, F., P. D. Markham, R. Gendelman, R. C. Gallo, and B. Ensoli. 1997. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 158:1887.
35. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, N. Ferrara, J. A. Sonnabend, A. Pintus, G. Zon, et al. 1998. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to induce angiogenesis, vascular permeability and KS lesion development. Am. J. Pathol. 152:1433.
36. Cornali, E., C. Zietz, R. Benelli, W. Weninger, L. Masiello, G. Breier, E. Tschachler, A. Albini, and M. Stürzl. 1996. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149:1851.
37. Friedlander, H. P., P. C. Brooks, R. W. Shaffer, C. M. Kincaid, J. A. Varner, and D. A. Cheresh 1995. Definition of two angiogenic pathways by distinct αν integrins. Science 270:1500.
38. Hammes, H. P., M. Brownlee, A. Jonczyk, A. Sutter, and K. T. Preissner. 1996. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2:529.
39. Pandita, R., E. Poesik, and B. B. Aggarwal. 1992. Interferon-γ induces cell surface expression of both types of tumor necrosis factor receptors. FEBS Lett. 312:87.
40. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and TNF α each up-regulate both the expression of IFN-γ and enhance IFN-γ-induced HLA-DR expression on human monocytes and on a human monocytic cell line. J. Immunol. 150:1205.
41. Pober, J. S., M. A. Gimbronc Jr., L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothkin, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J. Immunol. 137:1893.
42. 3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood. In press.
43. Hynes, R. O. 1992. Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11.
44. Ingber, D. E., D. Prusty, J. Y. Frangioni, E. J. Cragoe, C. Lechene, and M. Schwartz. 1990. Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J. Cell Biol. 110:1803.
45. 1 integrins during human melanoma cell invasion. Cancer Res. 53:3411.
46. 3 for angiogenesis. Science 264:569.
47. 3. Cell 85:683.
48. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1 Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. J. Immunol. 156:1638.
49. Ganju, R. K., N. Munshi, B. C. Nair, Z. Y. Liu, P. Gill, and J. E. Groopman. 1998. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinase, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72:6131.
50. FAK and is associated with phosphoinositide 3-kinase in PC12 cells. AIDS 12:1275.
51. Albini, A., R. Soldi, D. Giunciuglio, R. Giraudo, R. Benelli, L. Primo, D. Noonan, M. Salio, G. Camussi, W. Rockl, and F. Bussolino. 1996. The angiogenesis induced by HIV-1 Tat protein is mediated by the FIK-1/KDR receptor on vascular endothelial cells. Nat. Med. 2:1371.